News Focus
News Focus
Followers 236
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: Lungman424 post# 7595

Tuesday, 02/05/2008 9:10:56 AM

Tuesday, February 05, 2008 9:10:56 AM

Post# of 19309
LOL;;;;;;

Of course guys like lake and polly are short there is no law against it. Trading or playing off fluctuations is a good way to prevent yourself from getting rich with this stock. It would not be much of a surprise if the PPS does not take off at this juncture. After all this is a regulatory event, an important one, but not a financial event, and as an earlier poster noted, immunology is not likely a problem, money is.

Non the less trading the stock is foolish. This p3 milestone will in all likelyhood lead to a partnership (probably in the near future) which combined with Atryn revenues anticipated in 2009 should pretty much solidify GTCB's financial situation, ie. they will be making enough money to fund operations for the forseeable future. The market will understand this,,, on anouncement of a favorable partnership most likely the stock will gap, that means move up so fast that if you are trading it you might lose your position, if you are short you might lose alot of money.

Better to think of GTCBs shares as options. Options without an expiration date, (remember in options you pay for time) do not let people buy your timeless options too cheaply.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today